Page last updated: 2024-08-24

adenosine and Androgen-Independent Prostatic Cancer

adenosine has been researched along with Androgen-Independent Prostatic Cancer in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (33.33)	24.3611
2020's	2 (66.67)	2.80

Authors

Authors	Studies
Bauer, TM; Bendell, JC; Chen, H; Choe, JH; Das, M; Drake, CG; Falchook, GS; George, DJ; Hattersley, MM; Karlix, JL; Kumar, R; Lim, EA; Moorthy, G; Patel, MR; Pilling, EA; Pouliot, GP; Russell, DL; Sachsenmeier, KF; Sidders, BS; Ulahannan, S	1
Alimonti, A; Crespo, M; de Bono, JS; Dolling, D; Drake, CG; Ferreira, A; Figueiredo, I; Gil, V; Guo, C; Gurel, B; Lambros, MBK; Mehra, N; Neeb, A; Pereira, R; Petremolo, A; Rekowski, J; Rodrigues, DN; Seed, G; Sharp, A; Sumanasuriya, S; Terstappen, L; Yuan, W	1
Aparicio, A; Chung, W; Estécio, MR; Issa, JP; Jelinek, J; Kleb, B; Maity, S; Marquez, VE; Navone, NM; Tahir, S; Tzelepi, V; Zhang, J	1

Trials

1 trial(s) available for adenosine and Androgen-Independent Prostatic Cancer

Article	Year
Phase Ia/b, Open-Label, Multicenter Study of AZD4635 (an Adenosine A2A Receptor Antagonist) as Monotherapy or Combined with Durvalumab, in Patients with Solid Tumors. Clinical cancer research : an official journal of the American Association for Cancer Research, 2022, 11-14, Volume: 28, Issue:22 Topics: Adenosine; Adenosine A2 Receptor Antagonists; Antineoplastic Combined Chemotherapy Protocols; B7-H1 Antigen; Carcinoma, Non-Small-Cell Lung; Humans; Lung Neoplasms; Male; Prostatic Neoplasms, Castration-Resistant; Purinergic P1 Receptor Antagonists; Receptor, Adenosine A2A	2022

Article

Year

Phase Ia/b, Open-Label, Multicenter Study of AZD4635 (an Adenosine A2A Receptor Antagonist) as Monotherapy or Combined with Durvalumab, in Patients with Solid Tumors.

Clinical cancer research : an official journal of the American Association for Cancer Research, 2022, 11-14, Volume: 28, Issue:22

Topics: Adenosine; Adenosine A2 Receptor Antagonists; Antineoplastic Combined Chemotherapy Protocols; B7-H1 Antigen; Carcinoma, Non-Small-Cell Lung; Humans; Lung Neoplasms; Male; Prostatic Neoplasms, Castration-Resistant; Purinergic P1 Receptor Antagonists; Receptor, Adenosine A2A

2022

Other Studies

2 other study(ies) available for adenosine and Androgen-Independent Prostatic Cancer

Article	Year
CD38 in Advanced Prostate Cancers. European urology, 2021, Volume: 79, Issue:6 Topics: Adenosine; Humans; Male; Prostate; Prostatic Neoplasms, Castration-Resistant; Retrospective Studies; RNA, Messenger	2021
Differentially methylated genes and androgen receptor re-expression in small cell prostate carcinomas. Epigenetics, 2016, 03-03, Volume: 11, Issue:3 Topics: Adenosine; Animals; Carcinoma, Small Cell; Cell Line, Tumor; Cell Lineage; CpG Islands; DNA Methylation; Enhancer of Zeste Homolog 2 Protein; Gene Expression Regulation, Neoplastic; Humans; Male; Mice; Promoter Regions, Genetic; Prostatic Neoplasms, Castration-Resistant; Receptors, Androgen; Xenograft Model Antitumor Assays	2016

Article

Year

CD38 in Advanced Prostate Cancers.

European urology, 2021, Volume: 79, Issue:6

Topics: Adenosine; Humans; Male; Prostate; Prostatic Neoplasms, Castration-Resistant; Retrospective Studies; RNA, Messenger

2021

Differentially methylated genes and androgen receptor re-expression in small cell prostate carcinomas.

Epigenetics, 2016, 03-03, Volume: 11, Issue:3

Topics: Adenosine; Animals; Carcinoma, Small Cell; Cell Line, Tumor; Cell Lineage; CpG Islands; DNA Methylation; Enhancer of Zeste Homolog 2 Protein; Gene Expression Regulation, Neoplastic; Humans; Male; Mice; Promoter Regions, Genetic; Prostatic Neoplasms, Castration-Resistant; Receptors, Androgen; Xenograft Model Antitumor Assays

2016